Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
General Anesthesia Emergence Induced by Methylphenidate
- Conditions
- Interventions
- First Posted Date
- 2014-12-30
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Nicoleta Stoicea
- Target Recruit Count
- 54
- Registration Number
- NCT02327195
- Locations
- 🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2014-12-25
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02326038
- Locations
- 🇳🇱
Orbis Medical Centre, Sittard-Geleen, Limburg, Netherlands
Psychostimulants Effects on Brain Functional Connectivity in Youth With Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2014-12-17
- Last Posted Date
- 2014-12-17
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT02318017
- Locations
- 🇮🇱
Sheba medical center, Tel Hashomer, Israel
A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers
- First Posted Date
- 2014-10-16
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 97
- Registration Number
- NCT02265718
- Locations
- 🇺🇸
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
🇺🇸Broward Research Group, Hollywood, Florida, United States
🇺🇸Jasper Clinic, Inc., Kalamazoo, Michigan, United States
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
- Conditions
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Registration Number
- NCT02247986
Effect of Methylphenidate on Ecologic Function in Paediatric Acquired Brain Injury Population
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Loewenstein Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT02227056
- Locations
- 🇮🇱
Loewenstein Rehabilitation Hospital Center, Raanana, Israel
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
- Conditions
- Interventions
- First Posted Date
- 2014-08-26
- Last Posted Date
- 2019-11-15
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 11
- Registration Number
- NCT02225106
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
- Conditions
- Interventions
- First Posted Date
- 2014-07-02
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Meir Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT02180529
- Locations
- 🇮🇱
Clalit Health Service, Beer-Sheva, Israel
Methylphenidate Treatment of Attention Deficits in Epilepsy
- Conditions
- Interventions
- First Posted Date
- 2014-07-01
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Kimford Jay Meador
- Target Recruit Count
- 55
- Registration Number
- NCT02178995
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Methylphenidate Effect on Humphrey Visual Fields
- Conditions
- Interventions
- First Posted Date
- 2014-06-12
- Last Posted Date
- 2018-04-11
- Lead Sponsor
- Rabin Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT02162381
- Locations
- 🇮🇱
Rabin Medical Center - Beilinson campus, Petah-Tikva, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.